Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Aclarion Inc
ACON
Healthcare
Biotechnology
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the...
spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ACON)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Sep 12, 2024 1:15pm
Aclarion Provides Corporate Update on Nociscan AI Technology
JUST IN: $ACON Aclarion Provides Corporate Update on Nociscan AI Technology MilestonesSuccessful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Sep 06, 2024 12:02pm
Aclarion Added to PRISM Emerging Medical Devices Index
News; $ACON Aclarion Added to PRISM Emerging Medical Devices IndexCompany's industry-first technology addresses chronic low back pain Aclarion secured its first commercial agreement with Michigan&
...more
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 03, 2024 5:56am
Aclarion, Inc. (NASDAQ:ACON) – A Promising Medtech Inn
https://beyondspx.com/2024/08/02/aclarion-inc-nasdaqacon-a-promising-medtech-innovator-navigating-challenges/
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jun 25, 2024 7:30pm
Aclarion Expands Commercial Engagement With The London Clini
Breaking News: $ACON Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater LondonEstablished in 1932, the London Clinic is the UK@s Most Renowned
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 26, 2024 5:30pm
US Stocks Edge Higher; Domino's Posts Upbeat Earnings | Benz
JUST IN: $ACON US Stocks Edge Higher; Domino's Posts Upbeat Earnings | BenzingaU.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 50 points on Monday.Following
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 26, 2024 5:15pm
Aclarion Announces Pricing of $3.0 Million Public Offering
NEWS: $ACON Aclarion Announces Pricing of $3.0 Million Public OfferingBROOMFIELD, CO - ( NewMediaWire ) - February 26, 2024 - Aclarion, Inc. (“Aclarion” or the “
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jan 29, 2024 6:15pm
Thinking about buying stock in Spectral AI, Applied UV, Adob
NEWS: $ACON Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion?Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion? PR Newswire
...more
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Dec 20, 2023 2:54pm
RE:ACON ....Told ya...post removed for "potty mouth"
Oh Boy ....The SH Cops just reduced my SH Reputation score downward to 58....what am I going to dooooooooooooo boooohooooohoooo
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 20, 2023 2:00pm
ACON ....Told ya...post removed for "potty mouth"
SH must be Bible Thumpers
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 20, 2023 8:58am
ACON..... I do believe theres a financing in the making
https://www.sec.gov/ix?doc=/Archives/edgar/data/1635077/000168316823008784/aclarion_s1.htm
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 14, 2023 11:27am
New Press Release - Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI
BROOMFIELD, CO, June 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of...
read article.
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jun 08, 2023 10:08am
ACON..... I rest my case
Done like dinner
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jun 08, 2023 9:49am
ACON....has to hold $1.41
Or it's done
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jun 08, 2023 9:48am
ACON ...early a.m runner on NR
However....typical start....How to burn Retail in the 1st 5 mins LoL
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 23, 2023 7:30am
New Press Release - Aclarion's Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD
Development of This Program Supports Aclarion’s Commitment to Lead With Strong Clinical Evidence and Engage the Payer Community Through Key Opinion Leader AdvocacyAclarion to Participate in Upcoming ISASS 2023 on June 1-3, 2023 in San Francisco, CA Where Their Health Economics Outcomes Abstract...
read article.
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.
Growth Rocket 2025 – Why dynaCERT is in the Spotlight